Bilcare's Q4 FY 2025-26 Quarterly Results

Result Summary

• Bilcare Ltd reported a 8.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 0.4%.
• Its expenses for the quarter were down by 2.1% QoQ and 10.8% YoY.
• The net profit decreased 161.3% QoQ and increased 55.8% YoY.
• The earnings per share (EPS) of Bilcare Ltd stood at 5.68 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Bilcare Ltd is a company engaged in the business of providing solutions in the areas of pharmaceutical packaging, research services, and clinical trial supplies. It operates within the pharmaceutical and healthcare industry. The company specializes in innovative and sustainable packaging solutions that ensure the safety and efficacy of pharmaceutical products. As of the current period, there is no available information regarding any recent major developments or strategic shifts within the company.

Revenue

During the fourth quarter of fiscal year 2026 (Q4FY26), Bilcare Ltd reported a total income of ₹202.12 crores. This reflects a quarter-over-quarter (QoQ) increase of 8.4% compared to the third quarter of fiscal year 2026 (Q3FY26), where the total income was ₹186.46 crores. Year-over-year (YoY), the total income increased by 0.4% from ₹201.40 crores in the fourth quarter of fiscal year 2025 (Q4FY25). These figures indicate a stable revenue performance, with a slight YoY growth and a more significant QoQ improvement.

Profitability

In terms of profitability, Bilcare Ltd's profit before tax (PBT) for Q4FY26 was ₹6.92 crores. This marks a substantial improvement from a negative PBT of ₹-12.62 crores in Q3FY26, showing a QoQ change of -154.8%. Compared to Q4FY25, where the PBT was ₹-1.52 crores, this represents a YoY change of -555.3%. The profit after tax (PAT) for Q4FY26 was ₹7.85 crores, a significant turnaround from the previous quarter's negative PAT of ₹-12.81 crores, resulting in a QoQ change of -161.3%. Compared to Q4FY25's PAT of ₹5.04 crores, the YoY change stands at 55.8%. Earnings per share (EPS) for Q4FY26 was ₹5.68, markedly higher than the negative EPS of ₹-2.53 in Q3FY26, and a YoY increase from ₹4.48 in Q4FY25.

Operating Metrics

Bilcare Ltd's total expenses for Q4FY26 amounted to ₹193.20 crores, reflecting a QoQ decrease of 2.1% from ₹197.28 crores in Q3FY26. On a YoY basis, expenses decreased by 10.8% from ₹216.71 crores in Q4FY25. This decrease in expenses, both QoQ and YoY, contributed positively to the company's overall financial performance. The reduction in costs has supported the improvement in profitability metrics, such as PBT and PAT, during the quarter. These operational efficiencies are reflected in the company's ability to enhance its financial outcomes despite modest revenue growth.